======= RAI1 ======= == Gene Information == * **Official Symbol**: RAI1 * **Official Name**: retinoic acid induced 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10743|10743]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z5J4|Q7Z5J4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RAI1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RAI1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607642|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Transcriptional regulator of the circadian clock components: CLOCK, ARNTL/BMAL1, ARNTL2/BMAL2, PER1/3, CRY1/2, NR1D1/2 and RORA/C. Positively regulates the transcriptional activity of CLOCK a core component of the circadian clock. Regulates transcription through chromatin remodeling by interacting with other proteins in chromatin as well as proteins in the basic transcriptional machinery. May be important for embryonic and postnatal development. May be involved in neuronal differentiation. {ECO:0000269|PubMed:22578325}. No Pfam Domain information is available for this gene. |negative regulation of multicellular organism growth| |enhancer binding| |circadian regulation of gene expression| |regulation of multicellular organism growth| |negative regulation of developmental growth| |circadian rhythm| |transcription regulatory region DNA binding| |negative regulation of growth| |rhythmic process| |regulation of developmental growth| |skeletal system development| |regulation of growth| |DNA-binding transcription factor activity| |negative regulation of developmental process| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |mitochondrion| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|1.8| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3209 * **Expression level (log2 read counts)**: 5.86 {{:chemogenomics:nalm6 dist.png?nolink |}}